Skip to Content

M162 M162 (Didanosine Delayed Release 400 mg)

Pill with imprint M162 M162 is White & Yellow, Capsule-shape and has been identified as Didanosine delayed release 400 mg. It is supplied by Mylan Pharmaceuticals Inc..

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M162 M162

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide